Ota Erika, Tobe-Gai Ruoyan, Mori Rintaro, Farrar Diane
Department of GlobalHealth Policy, Graduate School ofMedicine, The University of Tokyo, Tokyo, Japan.
Cochrane Database Syst Rev. 2012 Sep 12(9):CD000032. doi: 10.1002/14651858.CD000032.pub2.
Gestational weight gain is positively associated with fetal growth, and observational studies of food supplementation in pregnancy have reported increases in gestational weight gain and fetal growth.
To assess the effects of advice during pregnancy to increase energy and protein intake, or of actual energy and protein supplementation, on energy and protein intakes, and the effect on maternal and infant health outcomes.
We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (22 July 2011) and contacted researchers in the field. We updated the search on 12 July 2012 and added the results to the awaiting classification section of the review.
Randomised controlled trials of dietary advice to increase energy and protein intake, or of actual energy and protein supplementation, during pregnancy.
Two review authors independently assessed trials for inclusion and assessed risk of bias. Two review authors independently extracted data and checked for accuracy. Extracted data were supplemented by additional information from the trialists we contacted.
We examined 110 reports corresponding to 46 trials. Of these trials, 15 were included, 30 were excluded, and one is ongoing. Overall, 15 trials involving 7410 women were included.Nutritional advice (four trials, 790 women)Women given nutritional advice had a lower relative risk of having a preterm birth (two trials, 449 women) (risk ratio (RR) 0.46, 95% CI 0.21 to 0.98 ), head circumference at birth was increased in one trial (389 women) (mean difference (MD) 0.99 cm, 95% CI 0.43 to 1.55) and protein intake increased (three trials, 632 women) (protein intake: MD +6.99 g/day, 95% CI 3.02 to 10.97). No significant differences were observed on any other outcomes.Balanced energy and protein supplementation (11 trials, 5385 women)Risk of stillbirth was significantly reduced for women given balanced energy and protein supplementation (RR 0.62, 95% CI 0.40 to 0.98, five trials, 3408 women), mean birthweight was significantly increased (random-effects MD +40.96 g, 95% CI 4.66 to 77.26 , Tau(2)= 1744, I(2) = 44%, 11 trials, 5385 women). There was also a significant reduction in the risk of small-for-gestational age (RR 0.79, 95% CI 0.69 to 0.90, I(2) = 16%, seven trials, 4408 women). No significant effect was detected for preterm birth or neonatal death.High-protein supplementation (one trial, 1051 women)High-protein supplementation (one trial, 505 women), was associated with a significantly increased risk of small-for-gestational age babies (RR 1.58, 95% CI 1.03 to 2.41).Isocaloric protein supplementation (two trials, 184 women)Isocaloric protein supplementation (two trials,184 women) had no significant effect on birthweight and weekly gestational weight gain.
AUTHORS' CONCLUSIONS: This review provides encouraging evidence that antenatal nutritional advice with the aim of increasing energy and protein intake in the general obstetric population appears to be effective in reducing the risk of preterm birth, increasing head circumference at birth and increasing protein intake, there was no evidence of benefit or adverse effect for any other outcome reported.Balanced energy and protein supplementation seems to improve fetal growth, and may reduce the risk of stillbirth and infants born small-for-gestational age. High-protein supplementation does not seem to be beneficial and may be harmful to the fetus. Balanced-protein supplementation alone had no significant effects on perinatal outcomes.The results of this review should be interpreted with caution, the risk of bias was either unclear or high for at least one category examined in several of the included trials and the quality of the evidence was low for several important outcomes. Also the anthropometric characteristics of the general obstetric population is changing, therefore, those developing interventions aimed at altering energy and protein intake should ensure that only those women likely to benefit are included. Large, well designed randomised trials are needed to assess the effects of increasing energy and protein intake during pregnancy in women whose intake is below recommended levels.
孕期体重增加与胎儿生长呈正相关,关于孕期食物补充的观察性研究报告称,孕期体重增加和胎儿生长均有所增加。
评估孕期增加能量和蛋白质摄入量的建议,或实际进行能量和蛋白质补充,对能量和蛋白质摄入量的影响,以及对母婴健康结局的影响。
我们检索了Cochrane妊娠与分娩组试验注册库(2011年7月22日),并联系了该领域的研究人员。我们于2012年7月12日更新了检索,并将结果添加到综述的等待分类部分。
孕期增加能量和蛋白质摄入量的饮食建议,或实际进行能量和蛋白质补充的随机对照试验。
两位综述作者独立评估试验是否纳入,并评估偏倚风险。两位综述作者独立提取数据并检查准确性。提取的数据由我们联系的试验人员提供的其他信息补充。
我们审查了与46项试验对应的110份报告。其中,15项试验被纳入,30项试验被排除,1项试验正在进行。总体而言,纳入了涉及7410名女性的15项试验。
营养建议(4项试验,790名女性)
接受营养建议的女性早产的相对风险较低(2项试验,449名女性)(风险比(RR)0.46,95%置信区间0.21至0.98),一项试验(389名女性)中出生时头围增加(平均差(MD)0.99 cm,95%置信区间0.43至1.55),蛋白质摄入量增加(3项试验,6,32名女性)(蛋白质摄入量:MD +6.99 g/天,95%置信区间3.02至10.97)。在任何其他结局上均未观察到显著差异。
能量和蛋白质均衡补充(11项试验,5385名女性)
接受能量和蛋白质均衡补充的女性死产风险显著降低(RR 0.62,95%置信区间0.40至0.98,5项试验,3408名女性),平均出生体重显著增加(随机效应MD +40.96 g,95%置信区间4.66至77.26,Tau(2)= 1744,I(2) = 44%,11项试验,5385名女性)。小于胎龄儿的风险也显著降低(RR 0.79,95%置信区间0.69至0.90,I(2) = 16%,7项试验,4408名女性)。未检测到早产或新生儿死亡的显著影响。
高蛋白补充(1项试验,1051名女性)
高蛋白补充(1项试验,505名女性)与小于胎龄儿的风险显著增加相关(RR 1.58,95%置信区间1.03至2.41)。
等热量蛋白质补充(2项试验,184名女性)
等热量蛋白质补充(2项试验,184名女性)对出生体重和每周孕期体重增加无显著影响。
本综述提供了令人鼓舞的证据,即旨在增加一般产科人群能量和蛋白质摄入量的产前营养建议似乎可有效降低早产风险、增加出生时头围并增加蛋白质摄入量,对于报告的任何其他结局均无获益或不良影响的证据。能量和蛋白质均衡补充似乎可改善胎儿生长,并可能降低死产和小于胎龄儿出生的风险。高蛋白补充似乎并无益处,可能对胎儿有害。单纯的均衡蛋白质补充对围产期结局无显著影响。本综述的结果应谨慎解读,在纳入的多项试验中,至少有一类所检查的偏倚风险不明确或很高,且几个重要结局的证据质量较低。此外,一般产科人群的人体测量特征正在发生变化,因此,那些制定旨在改变能量和蛋白质摄入量的干预措施的人员应确保仅纳入可能获益的女性。需要进行大规模、设计良好的随机试验,以评估孕期能量和蛋白质摄入量低于推荐水平的女性增加能量和蛋白质摄入量的效果。